CTCBIO Statistics

Total Valuation

CTCBIO has a market cap or net worth of KRW 164.25 billion. The enterprise value is 181.73 billion.

Market Cap	164.25B
Enterprise Value	181.73B

Important Dates

The last earnings date was Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

CTCBIO has 23.91 million shares outstanding. The number of shares has increased by 0.16% in one year.

Current Share Class	n/a
Shares Outstanding	23.91M
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	+0.64%
Owned by Insiders (%)	6.12%
Owned by Institutions (%)	0.46%
Float	13.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.14
PB Ratio	2.36
P/TBV Ratio	2.40
P/FCF Ratio	69.69
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 93.12, with an EV/FCF ratio of 77.10.

EV / Earnings	-34.81
EV / Sales	1.26
EV / EBITDA	93.12
EV / EBIT	n/a
EV / FCF	77.10

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.45.

Current Ratio	1.18
Quick Ratio	0.63
Debt / Equity	0.45
Debt / EBITDA	16.84
Debt / FCF	13.95
Interest Coverage	-1.23

Financial Efficiency

Return on equity (ROE) is -6.53% and return on invested capital (ROIC) is -2.17%.

Return on Equity (ROE)	-6.53%
Return on Assets (ROA)	-1.55%
Return on Invested Capital (ROIC)	-2.17%
Return on Capital Employed (ROCE)	-4.33%
Revenue Per Employee	579.95M
Profits Per Employee	-20.97M
Employee Count	249
Asset Turnover	0.90
Inventory Turnover	2.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.70% in the last 52 weeks. The beta is 0.36, so CTCBIO's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-23.70%
50-Day Moving Average	7,040.60
200-Day Moving Average	7,294.50
Relative Strength Index (RSI)	43.97
Average Volume (20 Days)	42,739

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CTCBIO had revenue of KRW 144.41 billion and -5.22 billion in losses. Loss per share was -218.00.

Revenue	144.41B
Gross Profit	52.87B
Operating Income	-3.95B
Pretax Income	-5.32B
Net Income	-5.22B
EBITDA	1.95B
EBIT	-3.95B
Loss Per Share	-218.00

Full Income Statement

Balance Sheet

The company has 19.17 billion in cash and 32.87 billion in debt, giving a net cash position of -13.70 billion or -572.94 per share.

Cash & Cash Equivalents	19.17B
Total Debt	32.87B
Net Cash	-13.70B
Net Cash Per Share	-572.94
Equity (Book Value)	73.39B
Book Value Per Share	2,911.92
Working Capital	11.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.50 billion and capital expenditures -2.14 billion, giving a free cash flow of 2.36 billion.

Operating Cash Flow	4.50B
Capital Expenditures	-2.14B
Free Cash Flow	2.36B
FCF Per Share	98.58

Full Cash Flow Statement

Margins

Gross margin is 36.61%, with operating and profit margins of -2.74% and -3.62%.

Gross Margin	36.61%
Operating Margin	-2.74%
Pretax Margin	-3.68%
Profit Margin	-3.62%
EBITDA Margin	1.35%
EBIT Margin	-2.74%
FCF Margin	1.63%

Dividends & Yields

CTCBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.16%
Shareholder Yield	-0.16%
Earnings Yield	-3.18%
FCF Yield	1.43%

Stock Splits

The last stock split was on April 22, 2013. It was a forward split with a ratio of 1.1.

Last Split Date	Apr 22, 2013
Split Type	Forward
Split Ratio	1.1

Scores

CTCBIO has an Altman Z-Score of 1.86. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.86
Piotroski F-Score	n/a